Showing results (421-430 of 847) with videos related to
Sort By:
Pageof 85
JNCI Cancer Spectrum|July 31, 2019
Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug AdministrationSaya L Jacob, Erika Cornell, Michael Kwa, et al.JNCI Cancer Spectrum|July 31, 2019
High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in NeuroblastomaDivya Sahu, Shinn-Ying Ho, Hsueh-Fen Juan, et al.JNCI Cancer Spectrum|July 31, 2019
Affordability and Price Increases of New Cancer Drugs in Clinical Guidelines, 2007-2016Thomas J Hwang, Aaron S Kesselheim, Bishal GyawaliJNCI Cancer Spectrum|July 31, 2019
Risk of Congenital Malformations in Children Born Before Paternal CancerYahia Al-Jebari, Lars Rylander, Olof Ståhl, et al.JNCI Cancer Spectrum|July 31, 2019
A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional StagingGeorg Brunner, Achim Heinecke, Thomas M Falk, et al.JNCI Cancer Spectrum|July 31, 2019
Reliability of Oncology Value Framework Outputs: Concordance Between Independent Research GroupsJoseph C Del Paggio, Sierra Cheng, Christopher M Booth, et al.JNCI Cancer Spectrum|July 31, 2019
Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced CancerNicola Jane Lawrence, Felicia Roncolato, Andrew Martin, et al.JNCI Cancer Spectrum|July 31, 2019
Cardiovascular Care Among Cancer Survivors in the United StatesKevin A Pearlstein, Ramsankar Basak, Ronald C ChenJNCI Cancer Spectrum|July 31, 2019
Development and Validation of a Risk Score for Febrile Neutropenia After Chemotherapy in Patients With Cancer: The FENCE ScoreTheis Aagaard, Ashley Roen, Joanne Reekie, et al.JNCI Cancer Spectrum|July 31, 2019
Imprecise Kidney Function Thresholds in Cancer Clinical Trials and the Potential for HarmEdwin Wang, Jessica K Paulus, Douglas Hackenyos, et al.Pageof 85